Maintenance of zilucoplan efficacy in patients with generalised myasthenia gravis up to 24 weeks: a model-informed analysis

Background: Clinical efficacy of zilucoplan has been demonstrated in a 12-week, placebo-controlled, phase III study in patients with acetylcholine receptor autoantibody-positive generalised myasthenia gravis (gMG). However, placebo-controlled zilucoplan data past 12 weeks are not available. Objectiv...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Guillemette de la Borderie, Damien Chimits, Babak Boroojerdi, Melissa Brock, Petra W. Duda, Fiona Grimson, Paul Mahoney, Foteini Strimenopoulou, Gary Cutter, Inmaculada Aban, Susanna Brauner, Malin Petersson, James F. Howard, Nathan Bennett
Format:	Artigo
Sprog:	Inglês
Udgivet:	SAGE Publishing 2024-09-01
Serier:	Therapeutic Advances in Neurological Disorders
Online adgang:	https://doi.org/10.1177/17562864241279125
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!